Edition:
United States

Ypsomed Holding AG (YPSN.S)

YPSN.S on Swiss Exchange

143.70CHF
11:31am EDT
Change (% chg)

CHF1.70 (+1.20%)
Prev Close
CHF142.00
Open
CHF143.10
Day's High
CHF144.60
Day's Low
CHF140.30
Volume
3,318
Avg. Vol
15,786
52-wk High
CHF182.50
52-wk Low
CHF125.20

Chart for

About

Ypsomed Holding AG is a Switzerland-based holding company engaged in the manufacture of injection pens for pharmaceutical and biotech companies. The Company develops and manufactures injection systems for custom-made self-administration, and markets pen needles for the treatment of diabetes, growth disorders or infertility, as... (more)

Overall

Beta: 0.75
Market Cap(Mil.): CHF1,795.18
Shares Outstanding(Mil.): 12.65
Dividend: 1.40
Yield (%): 0.99

Financials

  YPSN.S Industry Sector
P/E (TTM): 34.33 37.38 30.20
EPS (TTM): 4.14 -- --
ROI: 15.39 14.29 12.77
ROE: 16.18 17.47 14.92

BRIEF-Ypsomed FY Net Profit Increases To CHF 52.1 Million

* FY CONSOLIDATED SALES OF CHF 466.1 MILLION (PRIOR YEAR: CHF 389.6 MILLION)

May 24 2018

BRIEF-Ypsomed Holding Establishes Its First Subsidiary In Canada

* ESTABLISHES ITS FIRST SUBSIDIARY IN NORTH AMERICA, CANADA Source text - https://bit.ly/2pNgRJw Further company coverage: (Gdynia Newsroom)

Mar 27 2018

BRIEF-Ypsomed sees temporary profit decline in 2019/20, then rebound

* YPSOMED SAYS FOR THE NEXT FINANCIAL YEAR 2018/19, YPSOMED CONTINUES TO EXPECT AN INCREASED OPERATING PROFIT

Mar 07 2018

Earnings vs. Estimates